These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31083597)

  • 1. Management of STEC Gastroenteritis: Is There a Role for Probiotics?
    Giordano M; Baldassarre ME; Palmieri V; Torres DD; Carbone V; Santangelo L; Gentile F; Panza R; Di Mauro F; Capozza M; Di Mauro A; Laforgia N
    Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31083597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection.
    Bruyand M; Mariani-Kurkdjian P; Gouali M; de Valk H; King LA; Le Hello S; Bonacorsi S; Loirat C
    Med Mal Infect; 2018 May; 48(3):167-174. PubMed ID: 29054297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating true incidence of O157 and non-O157 Shiga toxin-producing Escherichia coli illness in Germany based on notification data of haemolytic uraemic syndrome.
    Kuehne A; Bouwknegt M; Havelaar A; Gilsdorf A; Hoyer P; Stark K; Werber D;
    Epidemiol Infect; 2016 Nov; 144(15):3305-3315. PubMed ID: 27468812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study.
    Myojin S; Pak K; Sako M; Kobayashi T; Takahashi T; Sunagawa T; Tsuboi N; Ishikura K; Kubota M; Kubota M; Igarashi T; Morioka I; Miyairi I
    PLoS One; 2022; 17(2):e0263349. PubMed ID: 35120154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections.
    Wu CJ; Hsueh PR; Ko WC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):390-3. PubMed ID: 21862425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence.
    Mahat U; Matar RB; Rotz SJ
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27913. PubMed ID: 31286658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
    Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H
    Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome with mild renal involvement due to Shiga toxin-producing Escherichia coli (STEC) O145 strain.
    Pérez L; Apezteguía L; Piñeyrúa C; Dabezies A; Bianco MN; Schelotto F; Varela G
    Rev Argent Microbiol; 2014; 46(2):103-6. PubMed ID: 25011592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli].
    Loirat C
    Rev Prat; 2013 Jan; 63(1):11-6. PubMed ID: 23457821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).
    Caillaud C; Zaloszyc A; Licht C; Pichault V; Frémeaux-Bacchi V; Fischbach M
    Pediatr Nephrol; 2016 Jan; 31(1):157-61. PubMed ID: 26399238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.
    Werber D; Fruth A; Buchholz U; Prager R; Kramer MH; Ammon A; Tschäpe H
    Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):726-30. PubMed ID: 14614596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.
    Nitschke M; Sayk F; Härtel C; Roseland RT; Hauswaldt S; Steinhoff J; Fellermann K; Derad I; Wellhöner P; Büning J; Tiemer B; Katalinic A; Rupp J; Lehnert H; Solbach W; Knobloch JK
    JAMA; 2012 Mar; 307(10):1046-52. PubMed ID: 22416100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157, Germany, December 2016 to May 2017.
    Vygen-Bonnet S; Rosner B; Wilking H; Fruth A; Prager R; Kossow A; Lang C; Simon S; Seidel J; Faber M; Schielke A; Michaelis K; Holzer A; Kamphausen R; Kalhöfer D; Thole S; Mellmann A; Flieger A; Stark K
    Euro Surveill; 2017 May; 22(21):. PubMed ID: 28597831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary transmissions during the outbreak of Shiga toxin-producing Escherichia coli O104 in Hesse, Germany, 2011.
    Hauri A; Gotsch U; Strotmann I; Krahn J; Bettge-Weller G; Westbrock H; Bellinger O; Uphoff H
    Euro Surveill; 2011 Aug; 16(31):. PubMed ID: 21871215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.
    Freedman SB; Xie J; Neufeld MS; Hamilton WL; Hartling L; Tarr PI; ; Nettel-Aguirre A; Chuck A; Lee B; Johnson D; Currie G; Talbot J; Jiang J; Dickinson J; Kellner J; MacDonald J; Svenson L; Chui L; Louie M; Lavoie M; Eltorki M; Vanderkooi O; Tellier R; Ali S; Drews S; Graham T; Pang XL
    Clin Infect Dis; 2016 May; 62(10):1251-1258. PubMed ID: 26917812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of surveillance for infections with Shiga toxin-producing Escherichia coli (STEC) of serotype O104:H4 after the large outbreak in Germany, July to December 2011.
    Frank C; Milde-Busch A; Werber D
    Euro Surveill; 2014 Apr; 19(14):. PubMed ID: 24739983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).
    Khalid M; Andreoli S
    Pediatr Nephrol; 2019 Dec; 34(12):2495-2507. PubMed ID: 30382336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.